Managing hypertension in patients with chronic kidney disease

JAAPA. 2014 Sep;27(9):37-46. doi: 10.1097/01.JAA.0000453239.92473.41.

Abstract

Chronic kidney disease (CKD) and hypertension are intrinsically linked. Although 59% of the US population will be diagnosed with CKD during their lifetimes, mortality is usually due to a cardiovascular event. Sodium restriction and a combination of a renin-angiotensin-aldosterone medication and a calcium channel blocker are the most effective methods of managing hypertension in patients with CKD.

Publication types

  • Review

MeSH terms

  • Adrenergic alpha-Agonists / therapeutic use
  • Adrenergic beta-Antagonists / therapeutic use
  • Angiotensin Receptor Antagonists / therapeutic use
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Calcium Channel Blockers / therapeutic use
  • Diuretics / therapeutic use
  • Humans
  • Hypertension / complications
  • Hypertension / drug therapy*
  • Renal Insufficiency, Chronic / complications*

Substances

  • Adrenergic alpha-Agonists
  • Adrenergic beta-Antagonists
  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Calcium Channel Blockers
  • Diuretics